Xiaofang Hu

878 total citations
37 papers, 641 citations indexed

About

Xiaofang Hu is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Xiaofang Hu has authored 37 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Nephrology and 6 papers in Immunology. Recurrent topics in Xiaofang Hu's work include Dialysis and Renal Disease Management (4 papers), Gut microbiota and health (4 papers) and Advanced Glycation End Products research (4 papers). Xiaofang Hu is often cited by papers focused on Dialysis and Renal Disease Management (4 papers), Gut microbiota and health (4 papers) and Advanced Glycation End Products research (4 papers). Xiaofang Hu collaborates with scholars based in China, France and United States. Xiaofang Hu's co-authors include Zhicheng Gong, Jie Du, Yuhong Xie, Shaxi Ouyang, Yi Xiao, Qiong Huang, Yiming Zhou, Yuanliang Yan, Jianxiong Long and Xun Cheng and has published in prestigious journals such as Molecular Cell, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaofang Hu

33 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofang Hu China 15 340 111 83 78 71 37 641
Yan-Rong Yu China 18 267 0.8× 81 0.7× 56 0.7× 141 1.8× 43 0.6× 31 754
Yanjia Chen China 15 376 1.1× 98 0.9× 46 0.6× 98 1.3× 93 1.3× 37 811
Mei Xue China 15 226 0.7× 32 0.3× 78 0.9× 72 0.9× 60 0.8× 24 651
Tie Zhang China 15 153 0.5× 55 0.5× 57 0.7× 59 0.8× 39 0.5× 31 461
Jing Du China 10 254 0.7× 40 0.4× 162 2.0× 70 0.9× 88 1.2× 38 586
Fang Xiao China 14 200 0.6× 44 0.4× 123 1.5× 168 2.2× 85 1.2× 52 690
Xiaopeng Yuan China 15 253 0.7× 50 0.5× 41 0.5× 96 1.2× 79 1.1× 39 579
Ling Qin China 12 204 0.6× 112 1.0× 32 0.4× 153 2.0× 26 0.4× 29 537
Florin L. Craciun United States 13 310 0.9× 92 0.8× 30 0.4× 222 2.8× 99 1.4× 13 705

Countries citing papers authored by Xiaofang Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Hu more than expected).

Fields of papers citing papers by Xiaofang Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Hu. The network helps show where Xiaofang Hu may publish in the future.

Co-authorship network of co-authors of Xiaofang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Hu. A scholar is included among the top collaborators of Xiaofang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Hu. Xiaofang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yiwen, Zhi Yang, Xia Liu, et al.. (2025). Alterations in fecal microbiota composition and cytokine expression profiles in adolescents with depression: a case-control study. Scientific Reports. 15(1). 12177–12177. 6 indexed citations
2.
Wu, Xiaoqing, et al.. (2025). Procyanidin C1 ameliorates osteoarthritis through epigenetic modulation of RAGEs. Food & Function. 16(23). 9022–9032.
3.
4.
Zhou, Yuanyuan, Dingwen Zhang, Xiaofang Hu, et al.. (2025). Wearable sensors and machine learning fusion-based fall risk prediction in covert cerebral small vessel disease. Frontiers in Neuroscience. 19. 1493988–1493988.
5.
6.
Wu, Xiaoqing, et al.. (2024). The isoflavone corylin suppresses tumor growth and metastasis in renal cell carcinoma by regulating RAGE transcription. Journal of Functional Foods. 120. 106349–106349. 1 indexed citations
7.
Hu, Xiaofang, et al.. (2023). Myo-Inositol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy by Inhibiting PI3K/AKT Activation. Journal of Medicinal Food. 26(6). 368–378. 1 indexed citations
8.
Hu, Xiaofang, et al.. (2023). Knowledge, attitude, and practice of nephrologists on the decision for renal replacement therapy. BMC Public Health. 23(1). 654–654. 4 indexed citations
9.
Li, Tianxu, Xiaofang Hu, Huihui Zhang, et al.. (2021). Cloning, analysis, and anti–duck Tembusu virus innate immune response of Cherry Valley duck tripartite motif-containing 32. Poultry Science. 100(5). 101048–101048. 3 indexed citations
10.
Xie, Yuhong, Yi Xiao, Qiong Huang, et al.. (2020). Role of the CTRP6/AMPK pathway in kidney fibrosis through the promotion of fatty acid oxidation. European Journal of Pharmacology. 892. 173755–173755. 22 indexed citations
11.
Hu, Xiaofang, Jie Du, Yuhong Xie, et al.. (2020). Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study. BMC Nephrology. 21(1). 97–97. 61 indexed citations
12.
Liu, Hengdao, Lingli Guo, Junhui Xing, et al.. (2020). The protective role of DPP4 inhibitors in atherosclerosis. European Journal of Pharmacology. 875. 173037–173037. 32 indexed citations
13.
Liu, Gen, Huihui Zhang, Xiaofang Hu, et al.. (2020). High-mobility group box 1 protein (HMGB1) from Cherry Valley duck mediates signaling pathways and antiviral activity. Veterinary Research. 51(1). 12–12. 18 indexed citations
14.
Hu, Xiaofang, Hengdao Liu, Jie Du, et al.. (2019). The clinical significance of plasma CFHR 1–5 in lupus nephropathy. Immunobiology. 224(3). 339–346. 10 indexed citations
15.
Ma, Miaomiao, Xiaoli Zhu, Xiaofang Hu, et al.. (2016). β3-adrenoceptor impacts apoptosis in cultured cardiomyocytes via activation of PI3K/Akt and p38MAPK. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(1). 1–7. 4 indexed citations
16.
Yang, Huiying, Rongmei Qu, Xiaoshan Lin, et al.. (2015). IGF-1 from Adipose-Derived Mesenchymal Stem Cells Promotes Radioresistance of Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. 15(23). 10115–10119. 24 indexed citations
17.
Yang, Zhen, Tao Zhou, Linfeng Yang, et al.. (2015). Diagnostic performance of myocardial perfusion imaging with SPECT, CT and MR compared to fractional flow reserve as reference standard. International Journal of Cardiology. 190. 103–105. 9 indexed citations
18.
Yi, Bin, Xiaofang Hu, Hao Zhang, et al.. (2014). Nuclear NF-κB p65 in Peripheral Blood Mononuclear Cells Correlates with Urinary MCP-1, RANTES and the Severity of Type 2 Diabetic Nephropathy. PLoS ONE. 9(6). e99633–e99633. 45 indexed citations
19.
Long, Jianxiong, et al.. (2013). GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis. European Journal of Clinical Microbiology & Infectious Diseases. 32(7). 859–868. 38 indexed citations
20.
Xu, Lei, Jidong Zhu, Xiaofang Hu, et al.. (2007). c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1. Molecular Cell. 28(5). 914–922. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan-Rong Yu Breakdown of academic impact, for papers by Yanjia Chen Breakdown of academic impact, for papers by Mei Xue Breakdown of academic impact, for papers by Tie Zhang Breakdown of academic impact, for papers by Jing Du Breakdown of academic impact, for papers by Fang Xiao Breakdown of academic impact, for papers by Xiaopeng Yuan Breakdown of academic impact, for papers by Ling Qin Breakdown of academic impact, for papers by Florin L. Craciun
Rankless by CCL
2026